In the Matter of Roger Roy Larson and Joan Rosemary Larson, Debtors-Appellants
Debtors-appellants Roger and Joan Larson appeal from the district court’s judgment affirming a decision of the bankruptcy court, which determined that the Internal Revenue Service (IRS) had correctly made deficiency assessments against the Larsons for tax years 1974 and 1975, and that the tax liability was not dischargeable in bankruptcy. We affirm.
I. Background
In 1973, the Larsons founded Pharmaco, Inc., an Illinois corporation, to exploit certain inventions of Roger Larson. Pharma-co issued 800 of its initial 1,000 shares of stock to the Larsons in exchange for patent rights in the inventions. 1 The remaining 200 shares of Pharmaco stock were issued to 22 unrelated shareholders for a total capitalization of $25,000. By March 1974, Pharmaco needed to raise more funds to develop its products. Therefore, in 1974 and 1975, the Larsons sold most of their Pharmaco stock. The Larsons retained approximately $270,000 of the proceeds and transferred the remaining $1,000,000 to Pharmaco. The transfers to Pharmaco were made as soon as possible after the Larsons received the sales proceeds and always within one banking day of receipt. Despite this infusion of cash in ’74 and ’75, Pharmaco apparently continued to experience financial difficulties. In 1976, characterizing their earlier transfers of $1,000,-000 of proceeds from their stock sales as “loans” to Pharmaco, the Larsons forgave the resultant “debts.” Pharmaco nonetheless became insolvent in 1978.
Roger and Joan Larson reported only $130,000 of the proceeds of the 1974 stock sales — i.e., the amount they retained — on their 1974 individual income tax return. On their 1975 return they reported only the $140,000 they retained. The IRS subsequently determined that
all
of the gain on the sales of Pharmaco stock should have been treated as income to the Larsons and that their transfers of part of the proceeds to Pharmaco were contributions to capital. Thus, on September 12,1979, the IRS made deficiency assessments against the Larsons for an additional $198,000 tax due for 1974 and 1975. On October 15, 1979, the Lar-sons filed a petition in bankruptcy pursuant to Chapter 7 of the Bankruptcy Code, 11 U.S.C. § 701
et seq.,
which filing was, ae-
On March 19, 1981, the Larsons filed a complaint in the bankruptcy court to determine their tax liability and its discharge-ability. In two decisions — one following a remand from the district court 2 — the bankruptcy court held that: (1) the 1974 and 1975 deficiency assessments were not dis-chargeable in bankruptcy because they were assessed within 240 days of the filing of the bankruptcy petition; (2) the doctrine of equitable estoppel did not bar the IRS from collecting the taxes; (3) all of the gain from the Pharmaco stock sales should have been included in the Larsons’ individual income; (4) the transfers of the proceeds of those sales to Pharmaco constituted contributions to capital rather than loans; (5) upon Pharmaco’s insolvency, the Larsons’ losses were deductible as capital losses rather-than ordinary losses; and (6) pre-pe-tition interest on the tax assessments was not dischargeable in bankruptcy. The district court affirmed all of these determinations. The Larsons appeal, challenging the latter five of the bankruptcy court’s holdings. 3 For the reasons explained below, we find no merit in any of the Larsons’ challenges.
II. Equitable Estoppel
The Larsons claim that they filed for bankruptcy less than 240 days after the tax assessment, making the taxes nondis-chargeable, in reliance on the statements of two IRS agents. They contend that they agreed to drop claims against certain other IRS agents and file for bankruptcy because these two agents assured them that the tax assessments would be discharged in bankruptcy. According to the Larsons, they reasonably relied on the misrepresentations of agents of the IRS in filing their bankruptcy petition on October 15,1984, and the government is therefore estopped from collecting the taxes assessed.
“The general rule is that reliance on misinformation provided by a government employee does not provide a basis for an estoppel.”
Crown v. United States Railroad Retirement Bd.,
“[T]o succeed on a traditional estoppel defense, the litigant must prove (1) a misrepresentation by another party (2) which he reasonably relied upon (3) to his detriment.”
United States v. Asmar,
Moreover, because the Larsons were dealing with the government, they are charged with knowledge of the law “and may not rely on the conduct of Government agents contrary to law.”
Heckler v. Community Health Services of Crawford,
We therefore conclude, mindful of the “great caution” that we must exercise in applying the doctrine of equitable estoppel to the government, that both the bankruptcy court and the district court correctly refused to do so. The IRS is not estopped from assessing the taxes at issue.
III. Individual Income
The second determination that the Larsons challenge on appeal is the bankruptcy court’s finding, affirmed by the district court, that all of the proceeds of the sales of their Pharmaco stock were properly included in their individual income. The bankruptcy court found that the Larsons control over the disposition of the proceeds was sufficient to require them to report receipt of the proceeds as income. The Larsons contend that this finding is clearly
These facts give us no reason to depart from the long established principle that “[t]he power to dispose of income is the equivalent of ownership of it. The exercise of that power to procure the payment of income to another is the enjoyment and hence the realization of the income by him who exercises it.”
Helvering v. Horst,
We need not decide whether such a unilateral “commitment” could ever shield a taxpayer from tax liability based upon the receipt of funds so committed, though we have recently stated that “in tax law a payment attributable to a person’s earnings that bypasses him and goes to his designees is taxed as a payment to him.”
In re Kochell,
As the government points out, at least three facts support the lower courts’ conclusion. First, the Larsons sold stock that they personally owned. Second, Roger Larson alone determined the amount of the funds which were subsequently transferred to Pharmaco. And third, Larson purported to “loan” the funds to Pharmaco, receiving a promissory note in return. In the face of these facts, Larson’s letters to the stockholders, which did not in any way commit him to use any particular amount of the proceeds for Pharmaco’s benefit, are insufficient to establish that the Larsons acted as a mere “conduit” for the sales proceeds. Indeed, the letters themselves state that the proceeds would be “loaned” to Pharma-co, suggesting that they were the Larsons’ to “loan.” We therefore affirm the determination that all of the proceeds of the sales of Pharmaco stock were includable in the Larsons’ individual income.
IV. Contributions to Capital v. Loans
The Larsons next contend that, even if the proceeds of the stock sales were income to them, the subsequent transfers of the funds to Pharmaco were loans rather than contributions to capital.
5
This question has been variously described as one of fact and one of law.
Saviano v. Commissioner,
The Larsons essentially make two arguments in an attempt to persuade this court otherwise. One is that it is simply “absurd” to believe that an individual would transfer over a million dollars to a company if he did not expect repayment. They thus argue that “[t]he size of the transfer in and of itself should be sufficient reason” for a finding that the transfers were loans. We find this argument unpersuasive. Certainly investors often contribute large sums of capital to corporations. This is so because such transfers, though characterized as “contributions to capital,” are not “contributions” in the sense of charitable donations. The distinction between a capital investor and a creditor is not that the latter expects repayment while the former does not. It is that the creditor expects repayment regardless of the debtor corporation’s success or failure, while the investor expects to make a profit (hoping for a larger profit than the creditor will make in interest) if as he no doubt devoutly wishes, the company is successful. We therefore reject the appellants’ notion that the size of a transfer alone can compel a finding that it is a loan rather than a capital contribution.
In a related argument, the Larsons contend that the primary basis for the bankruptcy court’s determination that the transfers at issue were capital contributions was Roger Larson’s testimony that he did not expect to be repaid. In context, Larson testified that he expected to be repaid
only if
Pharmaco was successful. This indicates that he acted as a classic capital investor
hoping
to make a profit, not as a creditor expecting to be repaid regardless of the company’s success or failure.
See, e.g., Saviano,
V. Applicability of the Com Products Doctrine
The Larsons next argue that, despite the characterization of their transfers of funds to Pharmaco as capital contributions, they are entitled to an ordinary loss deduction under the
Com Products
doctrine.
6
Because the courts below found
This contention is irrelevant given the Supreme Court’s decision in
Arkansas Best Corp. v. Commissioner,
— U.S. -,
[A] taxpayer’s motivation in purchasing an asset is irrelevant to the question whether the asset is ... within § 1221’s general definition of “capital asset.” Because the capital stock held by [the Lar-sons] falls within the broad definition of the term “capital asset” in § 1221 and is outside the classes of property excluded from capital-asset status, the loss ... is a capital loss.
Id. at 978.
VI. Dischargeability of Pre-petition Interest
Finally, the Larsons urge us, in cursory fashion, to reverse the bankruptcy
Section 101(4)(A) of the Bankruptcy Code, 11 U.S.C. § 101(4)(A), provides that the term “claim” means a “right to payment, whether or not such right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured, or unsecured.” This broad definition of a “claim” as a “right to payment” has been read to include interest.
See, e.g., In re Brinegar,
(b) ... [T]he court ... shall determine the amount of such claim ... as of the date of the filing of the petition, and shall allow such claim in such amount except to the extent that—
(2) such claim is for unmatured interest. ...
11 U.S.C. § 502 (emphasis added);
see In re Pharmadyne Laboratories, Inc.,
Here it is uncontested that the underlying tax liability is nondischargeable. The pre-petition interest is thus similarly non-dischargeable.
VII. Conclusion
For the foregoing reasons, we find no merit in any of the appellants’ arguments. The judgment of the district court, affirming the bankruptcy court, is in all respects
AFFIRMED.
Notes
. The agreement between Roger Larson and Pharmaco also entitled Larson to a 5% royalty on all revenues obtained by Pharmaco from sales of the products he had patented.
. On appeal from the bankruptcy court’s first decision, the district court found that the bankruptcy court’s initial order contained inconsistent characterizations of the transfers. The district court therefore reversed and remanded the case for a further determination of whether the transfers were capital contributions or loans. The district court also directed the bankruptcy court to reconsider whether the transfers fell within the ambit of the
Corn Products
doctrine,
see Corn Products Refining Co. v. Commissioner,
. On appeal it is undisputed that the taxes involved are nondischargeable under §§ 523(a)(1)(A) and 507(a)(6)(A)(ii) of the Bankruptcy Code. At the times relevant to this case, § 523 of Title 11 of the United States Code provided:
(а) A discharge under section 727, 1141, or 1328(b) of this title does not discharge an individual debtor from any debt
(1) for a tax ...—
(A) of the kind and for the periods specified in section 507(a)(2) or 507(a)(6) of this title. ...
Section 507(a) of Title 11 specified:
(б) ... allowed unsecured claims of governmental units, to the extent that such claims are for — (A) a tax on or measured by income or gross receipts — ... (ii) assessed within 240 days ... before the date of the filing of the
. For a recent discussion of the different approaches taken by the various circuits,
see United States
v.
Asmar,
. The proper characterization of the transfers determines the tax treatment to which the Lar-sons were entitled upon the insolvency of Phar-maco. If the transfers were loans, the Larsons could deduct the 1974 and 1975 loans as business bad debts in 1978 when Pharmaco became insolvent. See 26 U.S.C. § 166. Business bad debts are given ordinary loss treatment under § 166. If, on the other hand, the transfers were capital contributions, the amounts transferred would be added to the basis of the Larsons' stock. See 26 U.S.C. §§ 1011, 1012. Then, when the stock became worthless, the Larsons would be entitled to a capital loss equal to their basis. See 26 U.S.C. § 165(g).
. In Com Products Refining Co. v. Commissioner, the taxpayer was a manufacturer of products derived from corn which had purchased corn futures to assure a source of raw material for its business. The Supreme Court likened the taxpayer's corn futures contracts to an inventory of raw corn and held that, under the predecessor to § 1221, the taxpayer was not entitled to treat profits it made on the corn futures transactions as capital gains. Instead they were given ordinary income treatment.
From this seed the
"Com Products
doctrine" grew. Under that doctrine, various courts have held that the characterization of property, including capital stock, as a capital asset, depends on the extent to which a taxpayer's acquisition of the property stemmed from a "business” rather than an "investment” purpose, with a business motive leading to ordinary asset treatment and an investment motive leading to capital asset treatment. As the doctrine developed, the
. In their opening brief, filed while Arkansas Best was pending in the Supreme Court, the Larsons appeared to agree that the Court’s decision in that case would be dispositive. However, in their reply brief, filed after Arkansas Best was decided, they attempt to avoid application of the Court’s holding to their case by arguing that it represents a change in the law; the transactions at issue occurred in 1974 and 1975 and the law in effect at the time of the transactions is the law which should be applied in determining their effect. It could be answered simply that the Tax Code has not changed. Moreover, to the extent that the debtors argue that the decision in Arkansas Best interpreting the Code should not be applied retroactively to their case, they do not develop the argument. At any rate, we conclude that Arkansas Best may be applied retroactively.
Although the transaction at issue in
Arkansas Best
itself occurred between 1968 and 1975, the Court did not explicitly address the retroactivity issue. The test for determining whether a decision should be applied only prospectively is that enunciated by the Supreme Court in
Chevron Oil Co. v. Huson,
. Section 1221 of the Internal Revenue Code, 26 U.S.C. § 1221, defines the term "capital asset” as "property held by the taxpayer (whether or not connected with his trade or business)” and goes on to except from that general definition five specified categories of property. The first exception (the "inventory exclusion”) is for "stock in trade of the taxpayer or other property of a kind which would properly be included in the inventory of the taxpayer if on hand at the close of the taxable year, or property held by the taxpayer primarily for sale to customers in the ordinary course of his trade or business.” 26 U.S.C. § 1221(1).